Guardant Health
GH
#2613
Rank
โ‚น458.45 B
Marketcap
โ‚น3,711
Share price
-9.56%
Change (1 day)
101.05%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -โ‚น42.74 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น0.69 Billion. In 2023 the company made an earning of -โ‚น41.44 Billion, an increase over its 2022 earnings that were of -โ‚น56.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น42.74 Billion3.12%
2023 -โ‚น41.44 Billion-26.73%
2022 -โ‚น56.56 Billion69.96%
2021 -โ‚น33.28 Billion56.35%
2020 -โ‚น21.29 Billion252.69%
2019 -โ‚น6.04 Billion-17.22%
2018 -โ‚น7.29 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น18.39 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น43.66 Billion-1.56%๐Ÿ‡บ๐Ÿ‡ธ USA